• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

农村与城市退伍军人事务部医疗机构中阿片类药物使用障碍药物的可及性。

Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.

机构信息

Center to Improve Veteran Involvement in Care, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR, 97239, USA.

School of Public Health, Oregon Health & Science University, 840 SW Gaines St, Portland, OR, 97239, USA.

出版信息

J Gen Intern Med. 2023 Jun;38(8):1871-1876. doi: 10.1007/s11606-023-08027-4. Epub 2023 Jan 23.

DOI:10.1007/s11606-023-08027-4
PMID:36690913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9870655/
Abstract

BACKGROUND

For patients with opioid use disorder (OUD), medications for OUD (MOUD) reduce morbidity, mortality, and return to use. Nevertheless, a minority of patients receive MOUD, and underutilization is pronounced among rural patients.

OBJECTIVE

While Veterans Health Administration (VHA) initiatives have improved MOUD access overall, it is unknown whether access has improved in rural VA health systems specifically. How "Community Care," healthcare paid for by VHA but received from non-VA providers, has affected rural access is also unknown.

DESIGN

Data for this observational study were drawn from the VHA Corporate Data Warehouse. Facility rurality was defined by rural-urban commuting area code of the primary medical center. International Classification of Diseases codes identified patients with OUD within each year, 2015-2020. We included MOUD (buprenorphine, methadone, extended-release naltrexone) received from VHA or paid for by VHA but received at non-VA facilities through Community Care. We calculated average yearly MOUD receipt; linear regression of outcomes on study years identified trends; an interaction between year and rural status evaluated trend differences over time.

PARTICIPANTS

All 129 VHA Health Systems, a designation that encompasses one or more medical centers and their affiliated community-based outpatient clinics MAIN MEASURES: The average proportion of patients diagnosed with OUD that receive MOUD within rural versus urban VHA health care systems.

KEY RESULTS

From 2015 to 2020, MOUD access increased substantially: the average proportion of patients receiving MOUD increased from 34.6 to 48.9%, with a similar proportion of patients treated with MOUD in rural and urban systems in all years. Overall, a small proportion (1.8%) of MOUD was provided via Community Care, and Community Care did not disproportionately benefit rural health systems.

CONCLUSIONS

Strategies utilized by VHA could inform other health care systems seeking to ensure that, regardless of geographic location, all patients are able to access MOUD.

摘要

背景

对于阿片类药物使用障碍(OUD)患者,OUD 药物治疗(MOUD)可降低发病率、死亡率和复吸率。然而,只有少数患者接受 MOUD,农村患者的使用率明显较低。

目的

尽管退伍军人健康管理局(VHA)的举措总体上改善了 MOUD 的可及性,但具体而言,农村 VHA 卫生系统的 MOUD 可及性是否有所改善尚不清楚。VHA 支付但由非 VHA 提供者提供的“社区护理”如何影响农村地区的获得情况也尚不清楚。

设计

本观察性研究的数据来自 VHA 公司数据仓库。设施的农村性通过主要医疗中心的城乡通勤区代码来定义。国际疾病分类代码在 2015 年至 2020 年的每一年中确定 OUD 患者。我们纳入了 VHA 提供或 VHA 支付但通过社区护理在非 VHA 设施接受的 MOUD(丁丙诺啡、美沙酮、纳曲酮延长释放剂)。我们计算了每年平均 MOUD 接受率;对结果进行线性回归以确定研究年份的趋势;在年与农村状况之间的交互作用评估了随时间的趋势差异。

参与者

所有 129 个 VHA 医疗系统,这一名称涵盖了一个或多个医疗中心及其附属的社区门诊诊所。

主要测量指标

在农村与城市 VHA 医疗保健系统中,被诊断患有 OUD 的患者接受 MOUD 的平均比例。

结果

从 2015 年到 2020 年,MOUD 的可及性大幅增加:接受 MOUD 治疗的患者比例从 34.6%增加到 48.9%,所有年份农村和城市系统中接受 MOUD 治疗的患者比例相似。总体而言,通过社区护理提供的 MOUD 比例很小(1.8%),并且社区护理并没有不成比例地使农村卫生系统受益。

结论

VHA 采用的策略可以为其他寻求确保无论地理位置如何,所有患者都能够获得 MOUD 的医疗保健系统提供信息。

相似文献

1
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.农村与城市退伍军人事务部医疗机构中阿片类药物使用障碍药物的可及性。
J Gen Intern Med. 2023 Jun;38(8):1871-1876. doi: 10.1007/s11606-023-08027-4. Epub 2023 Jan 23.
2
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。
Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.
3
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.COVID-19 的影响以及快速放宽政策以扩大阿片类药物使用障碍(MOUD)药物获取:一项全国退伍军人健康管理局队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109678. doi: 10.1016/j.drugalcdep.2022.109678. Epub 2022 Nov 1.
4
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.
5
Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis.按种族类别分析住院期间阿片类药物使用障碍药物治疗的差异:回顾性队列分析。
Subst Abus. 2022;43(1):1251-1259. doi: 10.1080/08897077.2022.2074601.
6
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.改善美国退伍军人医疗保健系统中非成瘾诊所处方行为的干预措施后,阿片类药物使用障碍药物的可及性。
JAMA Netw Open. 2021 Dec 1;4(12):e2137238. doi: 10.1001/jamanetworkopen.2021.37238.
7
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人的远程医疗服务的接受情况、阿片类药物使用障碍药物的获得和保留情况,以及在 COVID-19 大流行之前和期间的药物治疗过量情况。
JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284.
8
Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.退伍军人肝硬化伴活跃阿片类药物使用障碍的药物治疗。
Am J Gastroenterol. 2021 Jul 1;116(7):1406-1413. doi: 10.14309/ajg.0000000000001228.
9
Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study.共同实施的策略:阿片类物质使用障碍学术推广活动对推进阿片类物质使用障碍药物治疗(ADaPT - OUD)研究的影响。
Implement Res Pract. 2023 Sep 14;4:26334895231199463. doi: 10.1177/26334895231199463. eCollection 2023 Jan-Dec.
10
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.在同时存在物质使用问题的退伍军人中治疗阿片类药物使用障碍:在初级保健、心理健康和疼痛环境中使用丁丙诺啡的提供者的定性研究。
Addict Sci Clin Pract. 2023 May 4;18(1):26. doi: 10.1186/s13722-023-00382-1.

引用本文的文献

1
Receipt of medications for opioid use disorder among rural and urban veterans health administration patients.农村和城市退伍军人健康管理局患者中用于阿片类药物使用障碍的药物接收情况。
Drug Alcohol Depend Rep. 2024 Dec 14;14:100311. doi: 10.1016/j.dadr.2024.100311. eCollection 2025 Mar.
2
Engaging healthcare teams to increase access to medications for opioid use disorder.让医疗团队参与进来,以增加阿片类药物使用障碍药物的可及性。
Health Serv Res. 2024 Dec;59 Suppl 2(Suppl 2):e14371. doi: 10.1111/1475-6773.14371. Epub 2024 Sep 8.
3
Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study.

本文引用的文献

1
Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.在 COVID-19 大流行期间,视频、电话和面对面使用丁丙诺啡治疗阿片类药物使用障碍的情况和保留率。
JAMA Netw Open. 2022 Oct 3;5(10):e2236298. doi: 10.1001/jamanetworkopen.2022.36298.
2
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.美联邦政策调整前后阿片类药物治疗项目纳洛酮剂量调整对美沙酮涉及的过量死亡的影响
JAMA Psychiatry. 2022 Sep 1;79(9):932-934. doi: 10.1001/jamapsychiatry.2022.1776.
3
不同种族和族裔的退伍军人在接受丁丙诺啡治疗阿片类药物使用障碍的保留率方面的差距是否在缩小?一项回顾性队列研究。
J Subst Use Addict Treat. 2024 Nov;166:209461. doi: 10.1016/j.josat.2024.209461. Epub 2024 Jul 25.
4
Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings.将丁丙诺啡用于治疗阿片类药物使用障碍融入农村基层医疗环境。
J Gen Intern Med. 2024 Sep;39(12):2142-2149. doi: 10.1007/s11606-024-08898-1. Epub 2024 Jul 2.
5
Improving access to buprenorphine for rural veterans in a learning health care system.在学习型医疗保健系统中改善农村退伍军人获得丁丙诺啡的机会。
Health Serv Res. 2024 Dec;59 Suppl 2(Suppl 2):e14346. doi: 10.1111/1475-6773.14346. Epub 2024 Jul 2.
6
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.患者对停止使用丁丙诺啡治疗阿片类药物使用障碍的看法。
J Addict Med. 2024;18(3):300-305. doi: 10.1097/ADM.0000000000001292. Epub 2024 Mar 18.
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
改善美国退伍军人医疗保健系统中非成瘾诊所处方行为的干预措施后,阿片类药物使用障碍药物的可及性。
JAMA Netw Open. 2021 Dec 1;4(12):e2137238. doi: 10.1001/jamanetworkopen.2021.37238.
4
Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.临床领导人和提供者对在退伍军人事务部设施中提供治疗阿片类药物使用障碍的药物的看法。
Addict Sci Clin Pract. 2021 Sep 6;16(1):55. doi: 10.1186/s13722-021-00263-5.
5
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.新冠疫情期间康涅狄格州美沙酮项目实践的变化及美沙酮过量致死率
J Subst Abuse Treat. 2021 Dec;131:108449. doi: 10.1016/j.jsat.2021.108449. Epub 2021 Apr 29.
6
The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.从一个开处方的枢纽来看,远程医疗和丁丙诺啡获取的交织扩张。
Prev Med. 2021 Nov;152(Pt 2):106603. doi: 10.1016/j.ypmed.2021.106603. Epub 2021 May 8.
7
Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.识别患有阿片类药物使用障碍的个体:阿片类药物使用、依赖和滥用的国际疾病分类诊断代码的有效性。
Drug Alcohol Depend. 2021 Apr 1;221:108583. doi: 10.1016/j.drugalcdep.2021.108583. Epub 2021 Feb 13.
8
Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.实施药师护理经理模式,以扩大阿片类药物使用障碍治疗药物的可及性。
Am J Health Syst Pharm. 2021 Feb 8;78(4):354-359. doi: 10.1093/ajhp/zxaa405.
9
Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study.基于行政数据的偶发性阿片类药物使用障碍(OUD)诊断的有效性:一项图表验证研究。
J Gen Intern Med. 2021 May;36(5):1264-1270. doi: 10.1007/s11606-020-06339-3. Epub 2020 Nov 11.
10
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.